Review
doi: 10.1056/NEJMra072739.
Cancer immunology
Affiliations
- PMID: 18565863
- DOI: 10.1056/NEJMra072739
Item in Clipboard
Review
Cancer immunology
N Engl J Med.
.
No abstract available
Comment in
-
Cancer immunotherapy--the endgame begins.N Engl J Med. 2008 Jun 19;358(25):2664-5. doi: 10.1056/NEJMp0803663. N Engl J Med. 2008. PMID: 18565858 Free PMC article. No abstract available.
-
Cancer immunotherapy.N Engl J Med. 2008 Sep 4;359(10):1072. doi: 10.1056/NEJMc081511. N Engl J Med. 2008. PMID: 18768956 Free PMC article. No abstract available.
Similar articles
-
Tumor immunology top 10 list.Immunol Rev. 2008 Apr;222:5-8. doi: 10.1111/j.1600-065X.2008.00623.x. Immunol Rev. 2008. PMID: 18363991 No abstract available.
-
Introduction: Cancer Immunology Special Issue-Immunotherapy.Int Immunol. 2016 Jul;28(7):317. doi: 10.1093/intimm/dxw028. Epub 2016 Jun 15. Int Immunol. 2016. PMID: 27313100 No abstract available.
-
Active Immunotherapy of Cancer.Immunol Invest. 2015;44(8):817-36. doi: 10.3109/08820139.2015.1096684. Immunol Invest. 2015. PMID: 26575466 Review.
-
From therapeutic monoclonal antibodies to therapeutic vaccines for cancer.Hum Vaccin. 2009 Jun;5(6):364-7. doi: 10.4161/hv.8990. Hum Vaccin. 2009. PMID: 19694082 No abstract available.
-
Future Research Goals in Immunotherapy.Surg Oncol Clin N Am. 2019 Jul;28(3):505-518. doi: 10.1016/j.soc.2019.02.006. Epub 2019 Apr 12. Surg Oncol Clin N Am. 2019. PMID: 31079803 Review.
Cited by
-
The complexity of p53-mediated metabolic regulation in tumor suppression.Semin Cancer Biol. 2022 Oct;85:4-32. doi: 10.1016/j.semcancer.2021.03.010. Epub 2021 Mar 27. Semin Cancer Biol. 2022. PMID: 33785447 Free PMC article. Review.
-
The tumor protection effect of high-frequency administration of whole tumor cell vaccine and enhanced efficacy by the protein component from Agrocybe aegerita.Int J Clin Exp Med. 2015 May 15;8(5):6914-25. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221228 Free PMC article.
-
Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model.Theor Biol Med Model. 2015 Jun 9;12:11. doi: 10.1186/s12976-015-0007-0. Theor Biol Med Model. 2015. PMID: 26054860 Free PMC article.
-
Th inducing POZ-Kruppel Factor (ThPOK) is a key regulator of the immune response since the early steps of colorectal carcinogenesis.PLoS One. 2013;8(1):e54488. doi: 10.1371/journal.pone.0054488. Epub 2013 Jan 17. PLoS One. 2013. PMID: 23349906 Free PMC article.
-
Dendritic-cell-based therapeutic cancer vaccines.Immunity. 2013 Jul 25;39(1):38-48. doi: 10.1016/j.immuni.2013.07.004. Immunity. 2013. PMID: 23890062 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
